Information for Qingdao Saber Technology Pharmaceutical
Page information·measured at build time
Technical and provenance information about Qingdao Saber Technology Pharmaceutical. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Qingdao Saber Technology Pharmaceutical |
|---|---|
| Default sort key | Qingdao Saber Technology Pharmaceutical |
| Namespace | Article (main) |
| Page kind | Organisation |
| Page length (source, bytes) | 14,594 |
| Rendered word count | 2,660 |
| Internal wiki links on the page | 47 |
| Defined citations | 8 |
| Top-level sections | 10 |
| Subsections | 1 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — organisation |
| Maintenance banners | primarysources |
| Indexing by robots | Allowed |
Edit history
| Page creator | GroupBuyGalen |
|---|---|
| Date of page creation | 11 June 2025 |
| Latest editor | VerifyVesna |
| Date of latest edit | 18 July 2026 |
| Total number of edits | 28 |
| Total number of distinct authors | 21 |
| Minor edits | 10 |
| Automated (bot) edits | 3 |
| Recent number of edits (last 90 days) | 5 |
| Talk page posts | 11 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| CheckSumChase | 4 | 14.3% | third-party testing and certificates of analysis |
| GroupBuyGalen | 2 | 7.1% | third-party testing and certificates of analysis |
| CiteBot | 2 | 7.1% | copy-editing and the manual of style |
| BlankVialBo | 2 | 7.1% | third-party testing and certificates of analysis |
| VerifyVesna | 2 | 7.1% | third-party testing and certificates of analysis |
| TirzTaxonomist | 1 | 3.6% | GLP-1 receptor agonists and related compounds |
| ReportReaderRilla | 1 | 3.6% | third-party testing and certificates of analysis |
| DrTitration | 1 | 3.6% | dosing, titration and injection practice |
| BlindSampleBrid | 1 | 3.6% | third-party testing and certificates of analysis |
| BatchNumberBede | 1 | 3.6% | third-party testing and certificates of analysis |
| IncretinIvo | 1 | 3.6% | incretin biology and receptor pharmacology |
| HOMA_Hettie | 1 | 3.6% | laboratory medicine and biomarkers |
Category membership
- Category:Peptide suppliers — 28 member pages
- Category:Suppliers in China — 28 member pages
- Category:Certificates of analysis — 34 member pages
- Category:Testing methodology — 39 member pages
- Category:Articles relying on primary sources (maintenance)